Chemotherapy and radiotherapy are commonly used in the treatment of tumors. Anthracyclines that commonly used in the treatment of cancer can be toxic to the heart. Radiation therapy can also cause myocardial cells damaging due to high therapeutic doses, resulting in cardiovascular related clinical diseases. Cardiotoxicity related to radiotherapy and chemotherapy affects the quality of life and survival rate of patients. Early detection of radiochemotherapy cardiotoxicity plays an important role in the long-term prognosis of patients. As an economical, non-invasive, repeatable, rapid and convenient examination method, echocardiography plays an irreplaceable role in the screening, diagnosis and monitoring of cardiotoxicity related to radiotherapy and chemotherapy. This article reviews the progress of echocardiography and its new technique in the evaluation of cardiotoxicity related to radiotherapy and chemotherapy.